SCHEMBL30714944

SCHEMBL30714944

CS(=O)(=O)c1cc(OC(F)(F)F)cc(C(N)=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 3/20 0.43
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
ALPL P05186 1/20 0.38
KAT6A Q92794 2/20 0.38
PTGS2 P35354 2/20 0.37
PIK3CD O00329 1/20 0.36
PIK3R1 P27986 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
PIK3R5 Q8WYR1 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
ABL1 P00519 2/20 0.35
BCR P11274 2/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22926045 0.86 AURKA (0.44) GPBAR1KAT6APTGS2LMNASMN1; SMN2
SCHEMBL31401431 0.85 GPBAR1 (0.45) GPBAR1ALPLKAT6APTGS2CA1
SCHEMBL29903378 0.79 VNN1 (0.36) LMNAPARP1LOX
SCHEMBL29482057 0.78 CES2 (0.46) SLC6A2SLC6A4PIK3CDPIK3R1PIK3CA
SCHEMBL30219246 0.78 CES2 (0.46) GPBAR1LMNA
SCHEMBL11296813 0.78 CES2 (0.46) GPBAR1LMNA
SCHEMBL30263072 0.77 NOTUM (0.43) GPBAR1PTGS2CA1CA2CA7
SCHEMBL29283393 0.77 NOTUM (0.43) GPBAR1PTGS2CA1CA2CA7
SCHEMBL30263067 0.74 NOTUM (0.40) GPBAR1PTGS2CA1CA2CA7
SCHEMBL29283387 0.74 NOTUM (0.40) GPBAR1PTGS2CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739682-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 EP claimed
WO-2025008058-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS JANSSEN PHARMACEUTICA NV (BE) 2025-01-09 WO claimed
EP-4739682-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 EP disclosed
WO-2025008058-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS JANSSEN PHARMACEUTICA NV (BE) 2025-01-09 WO disclosed
CN-117567338-A Novel heteroaryl triazole compounds as pesticides 拜耳公司 2024-02-20 CN disclosed